OUR PRODUCTS

MOBILE APPS

GENERAL INFO

FGEN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

FibroGen (FGEN) Earnings Date & Reports

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

FGEN is expected to report earnings to fall 280.00% to -9 cents per share on August 11

Q2'25

Est.

$-0.09

Q1'25

Beat

by $0.15

Q4'24

Beat

by $0.35

Q3'24

Beat

by $0.14

Q2'24

Beat

by $0.16

The last earnings report on May 13 showed earnings per share of 5 cents, beating the estimate of -10 cents. With 44.77K shares outstanding, the current market capitalization sits at 28.72M.

View a ticker or compare two or three

Compare

FGEN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For FGEN
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FGEN showed earnings on May 13, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of biotechnology-based drugs

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

409 Illinois Street

Phone

+1 415 978-1200

Employees

486

Web

https://www.fibrogen.com